Zimmer Biomet Holdings (ZBH) Non-Current Debt (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Non-Current Debt of $6.3 billion for Q2 2026, little changed on a QoQ basis from $6.3 billion in Q1 2026, and down 7.03% year-over-year from $6.8 billion in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Non-Current Debt (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Non-Current Debt for 18 years, with the latest figure at $6.3 billion in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 7.03% year-over-year to $6.3 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 7.03% decrease from a year earlier, with the FY2025 full-year figure at $6.9 billion, up 29.77% from the prior year.
- Non-Current Debt was $6.3 billion for Q2 2026 at Zimmer Biomet Holdings, roughly flat from $6.3 billion in the prior quarter.
- The five-year high for Non-Current Debt was $7.5 billion in Q3 2025, with the low at $4.0 billion in Q2 2024.
- Average Non-Current Debt over 5 years is $5.6 billion, with a median of $5.2 billion recorded in 2023.
- The largest YoY upside for Non-Current Debt was 417.2% in 2022 against a maximum downside of 29.88% in 2022.
- Over 5 years, Non-Current Debt stood at $5.2 billion in 2022, then declined by 5.52% to $4.9 billion in 2023, then advanced by 9.73% to $5.3 billion in 2024, then rose by 29.77% to $6.9 billion in 2025, then declined by 9.44% to $6.3 billion in 2026.
- The last three Non-Current Debt figures came in at $6.3 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.28 Bn |
| Mar 31, 2026 | 6.30 Bn |
| Dec 31, 2025 | 6.93 Bn |
| Sep 30, 2025 | 7.51 Bn |
| Jun 30, 2025 | 6.75 Bn |
| Mar 31, 2025 | 6.58 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.74 Bn |
| Jun 30, 2024 | 3.96 Bn |
| Mar 31, 2024 | 4.83 Bn |
| Dec 31, 2023 | 4.87 Bn |
| Sep 30, 2023 | 5.13 Bn |
| Jun 30, 2023 | 5.19 Bn |
| Mar 31, 2023 | 5.20 Bn |
| Dec 31, 2022 | 5.15 Bn |
| Sep 30, 2022 | 5.06 Bn |
| Jun 30, 2022 | 5.17 Bn |
| Mar 31, 2022 | 5.29 Bn |
| Dec 31, 2021 | 1.00 Bn |
| Sep 30, 2021 | 6.46 Bn |